Trial Profile
Phase IIb Study Comparing Tenecteplase to Alteplase in Acute Ischemic Stroke Within 3 to 4.5 Hours From Symptom Onset
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Tenecteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms TALISMAN
- 22 Sep 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 07 Jul 2014 New trial record